ProShares Ultra Nasdaq Biotechnology (BIB)

Assets	$89.24M
Expense Ratio	0.95%
PE Ratio	n/a
Shares Out	1.60M
Dividend (ttm)	$0.08
Dividend Yield	0.14%
Ex-Dividend Date	Mar 20, 2024
Payout Ratio	n/a
1-Year Return	+0.40%

Volume	4,890
Open	56.68
Previous Close	57.53
Day's Range	56.68 - 57.52
52-Week Low	40.10
52-Week High	62.45
Beta	1.57
Holdings	228
Inception Date	Apr 8, 2010

About BIB

Fund Home Page

The ProShares Ultra Nasdaq Biotechnology (BIB) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides 2x daily exposure to a modified market-cap-weighted index of biotechnology and pharmaceutical companies listed on NASDAQ. BIB was launched on Apr 8, 2010 and is issued by ProShares.

• Asset Class: Equity
• Category: Trading--Leveraged Equity
• Stock Exchange: NASDAQ
• Ticker Symbol: BIB
• ETF Provider: ProShares
• Index Tracked: NASDAQ / Biotechnology

Top 10 Holdings

150.62% of assets

Name	Symbol	Weight
NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG	n/a	46.05%
NASDAQ BIO INDEX SWAP BNP	n/a	35.89%
NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA	n/a	18.82%
NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE	n/a	14.64%
Amgen Inc.	AMGN	6.47%
NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL	n/a	6.39%
NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA	n/a	5.81%
Vertex Pharmaceuticals Incorporated	VRTX	5.77%
Regeneron Pharmaceuticals, Inc.	REGN	5.62%
Gilead Sciences, Inc.	GILD	5.16%

Dividends

Ex-Dividend	Amount	Pay Date
Mar 20, 2024	$0.04032	Mar 27, 2024
Dec 20, 2023	$0.03839	Dec 28, 2023
Dec 22, 2022	$0.01985	Dec 30, 2022
Sep 21, 2010	$0.011	Sep 28, 2010